Sign in
4

Changes in Ownership

Roivant Sciences Ltd. Filed Acc 0001140361-25-023521

President & COO sold 100,000 shares at $11.45 ($1,145,000)

  • President & COO acquired 100,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Venker Eric · President & COO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-20 Exercise or conversion : show line 1 in the form 10b5-1 +100,000 $3.85 $385,000 1,562,223 D
2025-06-20 Sale : show line 2 in the form 10b5-1 −100,000 $11.45 $1,145,000 1,462,223 D
Open-market sales · 100,000 sh · avg $11.45 · $1,145,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-20 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −100,000 8,238,897 D
Loading xslF345X05/form4.xml…